ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,828Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 384

$513K Total Retail Price of All Prescriptions

Rank: 59 out of 384

468 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
3% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 9,658 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $45 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 828 635 1 1
METFORMIN HCL 493 360 2 2
OMEPRAZOLE 452 347 3 8
RANITIDINE HCL 441 341 4 7
AMLODIPINE BESYLATE 410 328 5 3
ENALAPRIL MALEATE 361 287 6 6
LEVOTHYROXINE SODIUM 305 226 7 11
HYDROCHLOROTHIAZIDE 284 196 8 16
LOSARTAN POTASSIUM 247 162 9 5
FUROSEMIDE 243 201 10 17
LOSARTAN-HYDROCHLOROTHIAZIDE 230 213 11 10
PENTOXIFYLLINE 223 169 12 113
SYNTHROID 219 187 13 9
CARVEDILOL 216 180 14 23
GABAPENTIN 211 116 15 4
TRAMADOL HCL-ACETAMINOPHEN 210 172 16 13
ALENDRONATE SODIUM 207 173 17 20
LANTUS 197 122 18 42
METOPROLOL TARTRATE 186 141 19 15
ATORVASTATIN CALCIUM 154 111 20 22
ASPIRIN EC 143 130 21 31
FLUTICASONE PROPIONATE 141 97 22 61
GLIPIZIDE 134 82 23 27
NIFEDIPINE ER 132 111 24 106
HUMULIN N 124 58 25 57
QUINAPRIL HCL 124 89 25 110
GLIPIZIDE XL 121 79 27 115
PAROXETINE HCL 120 82 28 37
CLOPIDOGREL 114 96 29 30
NABUMETONE 113 55 30 34
IRBESARTAN 111 67 31 55
DONEPEZIL HCL 105 101 32 33
GLIPIZIDE ER 105 84 32 105
GEMFIBROZIL 105 58 32 74
SERTRALINE HCL 101 89 35 26
ATENOLOL 100 84 36 12
ISOSORBIDE MONONITRATE ER 98 74 37 28
PLAVIX 97 84 38 32
WARFARIN SODIUM 94 94 39 48
METOPROLOL SUCCINATE 93 55 40 21
DIOVAN 92 55 41 54
LYRICA 92 65 41 92
DOXAZOSIN MESYLATE 91 82 43 29
TAMSULOSIN HCL 89 78 44 25
ZOLPIDEM TARTRATE 89 82 44 19
AVAPRO 87 68 46 87
CLOTRIMAZOLE-BETAMETHASONE 86 61 47 58
HUMULIN 70-30 82 61 48 47
DIGOXIN 80 70 49 49
FAMOTIDINE 78 72 50 35
EVISTA 78 50 50 52
PRAVASTATIN SODIUM 74 46 52 24
PROVENTIL HFA 70 37 53 156
QVAR 69 62 54 188
LORATADINE 64 49 55 240
SINGULAIR 62 44 56 63
AMLODIPINE BESYLATE-BENAZEPRIL 61 36 57 43
NAMENDA 61 61 57 67
ONGLYZA 60 25 59 203
LANSOPRAZOLE 58 41 60 86
CRESTOR 58 50 60 45
INSULIN SYRINGE 54 31 62 46
AZITHROMYCIN 52 34 63 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 29, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.